glp-1 news november 2025 today Who Gets the Shot? Access by State Wegovy maker Novo Nordisk makes
Description
The program is designed for convenience and fast access, helping patients begin treatment quickly while minimizing in-person barriers
A higher proportion of the hormone therapy users achieved the weight loss that they were aiming for within one year
Nausea Management Tips
Daily Nutrient Intake*
Who and what will be impacted
Though only currently indicated for diabetes, the combined HbA1c and weight loss benefits make Mounjaro a standout in the class, creating a level of demand that has significantly grown the size of the overall GLP-1 market
